Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for Oral Mucositis Pain
NCT03469284Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2019
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in oral mucositis (OM), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2019; status: completed.
02
Drugs
methylene blue
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03469284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469284.